Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Total Non-Current Liabilities (2018 - 2020)

Black Diamond Therapeutics (BDTX) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $21.9 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Total Non-Current Liabilities rose 350.59% year-over-year to $21.9 million, compared with a TTM value of $21.9 million through Dec 2020, up 350.59%, and an annual FY2020 reading of $21.9 million, up 350.59% over the prior year.
  • Total Non-Current Liabilities was $21.9 million for Q4 2020 at Black Diamond Therapeutics, up from $19.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $21.9 million in Q4 2020 and bottomed at $4.9 million in Q4 2019.